Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNQ2 | O43526 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 2/20 | 0.38 |
| ▸ | DRD1 | P21728 | 2/20 | 0.38 |
| ▸ | DRD4 | P21917 | 2/20 | 0.38 |
| ▸ | DRD5 | P21918 | 2/20 | 0.38 |
| ▸ | DRD3 | P35462 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18378881 | 0.85 | KMT2A (0.38) | KCNQ2DRD2DRD1DRD4DRD5 | |
| SCHEMBL19709345 | 0.79 | DRD3 (0.40) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL19709442 | 0.77 | ADRA2A (0.38) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL24034527 | 0.74 | HPGD (0.41) | CYP2C19CYP1A2CYP2D6ALDH1A1HPGD | |
| SCHEMBL17377044 | 0.71 | KCNQ2 (0.37) | KCNQ2CYP2C19ALDH1A1HPGDKDM4E | |
| SCHEMBL13021599 | 0.70 | HPGD (0.44) | CYP2C19CYP1A2L3MBTL1ALDH1A1HPGD | |
| SCHEMBL23840301 | 0.69 | HPGD (0.44) | CYP2C19CYP1A2ALDH1A1HPGDKDM4E | |
| SCHEMBL24733006 | 0.68 | MAOA (0.38) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL18379188 | 0.68 | KDM4E (0.44) | DRD2DRD1DRD4DRD5DRD3 | |
| SCHEMBL17377155 | 0.68 | KCNQ2 (0.38) | KCNQ2KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11504443-B2 | Odor-modulating agent and odor-modulating method | YAMAMOTO PERFUMERY CO., LTD. (JP) | 2022-11-22 | — | — | US | claimed |
| CN-111565764-A | Odor conversion agent for conversion of odor of asphalt, sludge, sewage, ginkgo biloba, compost, marine animal, vegetable, garbage or coating, and odor conversion method for conversion of odor of asphalt, sludge, sewage, ginkgo biloba, compost, marine animal, vegetable, garbage or coating | 山本香料株式会社 | 2020-08-21 | — | — | CN | claimed |
| US-20190175777-A1 | ODOR-MODULATING AGENT AND ODOR-MODULATING METHOD | YAMAMOTO PERFUMERY CO., LTD. (JP) | 2019-06-13 | — | — | US | claimed |
| EP-3467078-A1 | ODOR-MODULATING AGENT AND ODOR-MODULATING METHOD | Yamamoto Perfumery Co. Ltd. (JP) | 2019-04-10 | — | — | EP | claimed |
| US-11504443-B2 | Odor-modulating agent and odor-modulating method | YAMAMOTO PERFUMERY CO., LTD. (JP) | 2022-11-22 | — | — | US | disclosed |
| WO-2022161420-A1 | CLASS OF HETEROAROMATIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海翊石医药科技有限公司 | 2022-08-04 | — | — | WO | disclosed |
| CN-114672359-A | Lubricating oil | 山本香料株式会社 | 2022-06-28 | — | — | CN | disclosed |
| CN-109689117-B | Odor conversion method | 山本香料株式会社 | 2021-03-30 | — | — | CN | disclosed |
| CN-111565764-A | Odor conversion agent for conversion of odor of asphalt, sludge, sewage, ginkgo biloba, compost, marine animal, vegetable, garbage or coating, and odor conversion method for conversion of odor of asphalt, sludge, sewage, ginkgo biloba, compost, marine animal, vegetable, garbage or coating | 山本香料株式会社 | 2020-08-21 | — | — | CN | disclosed |
| US-20190175777-A1 | ODOR-MODULATING AGENT AND ODOR-MODULATING METHOD | YAMAMOTO PERFUMERY CO., LTD. (JP) | 2019-06-13 | — | — | US | disclosed |
| EP-3467078-A1 | ODOR-MODULATING AGENT AND ODOR-MODULATING METHOD | Yamamoto Perfumery Co. Ltd. (JP) | 2019-04-10 | — | — | EP | disclosed |
| WO-2017214301-A1 | ANTI-EGFR ANTIBODY DRUG CONJUGATES | ABBVIE INC. (US) | 2017-12-14 | — | — | WO | disclosed |
| WO-2017214458-A2 | ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES | ABBVIE INC. (US) | 2017-12-14 | — | — | WO | disclosed |
| WO-2016094517-A1 | BCL-XL INHIBITORY COMPOUNDS AND ANTIBODY DRUG CONJUGATES INCLUDING THE SAME | ABBVIE INC. (US) | 2016-06-16 | — | — | WO | disclosed |
| US-20160158377-A1 | BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same | ABBVIE INC. (US) | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160158377-A1 | BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same | BCL2, BCL2L10, BAX | KCNQ2 3727/4885DRD2 2756/4885DRD1 3002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.